Case Study

Investing In Capacity – API Commercial Manufacturing

Source: Cambrex
iStock-188078261-lab-pharma-development-equipment

Cambrex was approached by a top 10 Asian pharmaceutical company looking to partner with a contract manufacturing organization (CMO) with commercial manufacturing capabilities and expertise, mid- to large-scale cGMP assets and exemplary quality systems and US FDA track record. The requirement was to find a cost effective process to produce the API for a new drug.

Cambrex had previously been working with the emerging company which initially developed the drug, so proactively approached the customer with innovative ideas for a new cost effective method. The original chemistry included a high number of chemical and purification steps and Cambrex believed a more efficient method was achievable. The customer felt that Cambrex had the necessary know-how, scale-up and commercial production expertise to meet its requirements.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: